NNNN
Anbio Biotechnology
4.80$
-13.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|
| 69.7% | -33.7% | 10.2% | 63.5% | – | – | |
| 0.3% | 0.1% | – | – | – | – | |
| 20.2% | -49.9% | -48.9% | 124.2% | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 51.7% | 4.1% | 2.4% | 8.5% | – | – | |
| -8.4% | 5.8% | -2.0% | -9.8% | – | – | |
| 113.1% | – | 10.6% | 62.1% | – | – | |
| 69.7% | -33.7% | 10.2% | 63.5% | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.